Total Payments
$18,709
2024 Payments
$2,004
Companies
59
Transactions
1,260
Medicare Patients
1,602
Medicare Billing
$132,333
Payment Breakdown by Category
Food & Beverage$18,556 (99.2%)
Education$153.61 (0.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $18,556 | 1,246 | 99.2% |
| Education | $153.61 | 14 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,921 | 97 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,669 | 110 | $0 (2024) |
| Novo Nordisk Inc | $1,531 | 121 | $0 (2024) |
| Lilly USA, LLC | $1,464 | 117 | $0 (2024) |
| ABBVIE INC. | $1,386 | 108 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $1,331 | 78 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,256 | 82 | $0 (2024) |
| PFIZER INC. | $859.09 | 64 | $0 (2024) |
| Amgen Inc. | $834.17 | 50 | $0 (2024) |
| Allergan, Inc. | $745.54 | 59 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,004 | 117 | Novo Nordisk Inc ($298.07) |
| 2023 | $2,128 | 147 | GlaxoSmithKline, LLC. ($361.15) |
| 2022 | $2,345 | 159 | ABBVIE INC. ($364.44) |
| 2021 | $2,405 | 148 | AbbVie Inc. ($487.25) |
| 2020 | $1,910 | 128 | Allergan, Inc. ($282.72) |
| 2019 | $2,477 | 160 | AstraZeneca Pharmaceuticals LP ($313.00) |
| 2018 | $2,289 | 171 | SANOFI-AVENTIS U.S. LLC ($319.71) |
| 2017 | $3,152 | 230 | SANOFI-AVENTIS U.S. LLC ($404.35) |
All Payment Transactions
1,260 individual payment records from CMS Open Payments — Page 1 of 51
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Diabetes Care | ||||||
| 12/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: DIABETES | ||||||
| 12/12/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $12.70 | General |
| Category: VACCINES | ||||||
| 12/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: RESPIRATORY | ||||||
| 11/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $11.33 | General |
| Category: DIABETES | ||||||
| 11/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.49 | General |
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Respiratory | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: VACCINES | ||||||
| 11/06/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.47 | General |
| 10/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: RESPIRATORY | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Respiratory | ||||||
| 10/07/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $12.59 | General |
| Category: Diabetes | ||||||
| 10/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: RESPIRATORY | ||||||
| 09/30/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 09/30/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $2.23 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 09/25/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $26.21 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Diabetes | ||||||
| 09/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: VACCINE | ||||||
| 09/05/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 399 | 486 | $72,176 | $34,128 |
| 2022 | 9 | 422 | 532 | $73,950 | $35,636 |
| 2021 | 7 | 365 | 421 | $67,850 | $32,468 |
| 2020 | 8 | 416 | 496 | $71,080 | $30,100 |
Total Patients
1,602
Total Services
1,935
Medicare Billing
$132,333
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 121 | 121 | $22,385 | $14,603 | 65.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 114 | 145 | $29,870 | $10,663 | 35.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 56 | 75 | $10,500 | $4,042 | 38.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 30 | 30 | $3,180 | $2,158 | 67.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 33 | 34 | $2,482 | $1,339 | 53.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 30 | 30 | $1,260 | $869.70 | 69.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 15 | 51 | $2,499 | $452.33 | 18.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 112 | 112 | $20,720 | $13,905 | 67.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 95 | 124 | $25,544 | $9,057 | 35.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 66 | 82 | $11,480 | $4,301 | 37.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 39 | 39 | $4,134 | $2,667 | 64.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 14 | 14 | $3,752 | $2,236 | 59.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 28 | 34 | $2,482 | $1,289 | 51.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 43 | 43 | $1,806 | $1,176 | 65.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 13 | 72 | $3,528 | $675.38 | 19.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 12 | 12 | $504.00 | $330.36 | 65.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 108 | 108 | $19,980 | $13,725 | 68.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 90 | 131 | $26,986 | $9,433 | 35.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 50 | 64 | $8,960 | $3,389 | 37.8% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 44 | 44 | $4,664 | $2,863 | 61.4% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 11 | 11 | $4,180 | $1,728 | 41.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 49 | 49 | $2,058 | $775.20 | 37.7% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 13 | 14 | $1,022 | $556.14 | 54.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 119 | 119 | $22,015 | $13,139 | 59.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 103 | 144 | $29,664 | $8,265 | 27.9% |
About Dr. Myles Jaynes, D.O
Dr. Myles Jaynes, D.O is a Family Medicine healthcare provider based in Baton Rouge, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/11/2013. The National Provider Identifier (NPI) number assigned to this provider is 1730420167.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Myles Jaynes, D.O has received a total of $18,709 in payments from pharmaceutical and medical device companies, with $2,004 received in 2024. These payments were reported across 1,260 transactions from 59 companies. The most common payment nature is "Food and Beverage" ($18,556).
As a Medicare-enrolled provider, Jaynes has provided services to 1,602 Medicare beneficiaries, totaling 1,935 services with total Medicare billing of $132,333. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Baton Rouge, LA
- Active Since 03/11/2013
- Last Updated 03/26/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1730420167
Products in Payments
- FARXIGA (Drug) $997.76
- TRELEGY ELLIPTA (Drug) $961.59
- JARDIANCE (Drug) $885.29
- VRAYLAR (Drug) $880.43
- UBRELVY (Drug) $548.03
- TRULICITY (Drug) $547.16
- Victoza (Drug) $509.47
- TOUJEO (Drug) $496.35
- TRINTELLIX (Drug) $462.27
- Ozempic (Drug) $452.65
- XARELTO (Drug) $396.74
- MOUNJARO (Drug) $363.89
- TRADJENTA (Drug) $352.85
- SOLIQUA (Drug) $331.24
- SHINGRIX (Biological) $330.40
- BREZTRI (Drug) $315.27
- Livalo (Drug) $287.70
- LINZESS (Drug) $280.13
- CHANTIX (Drug) $269.71
- Vascepa (Drug) $267.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Baton Rouge
Dr. Susan Julius, Md, MD
Family Medicine — Payments: $177,846
Family Medicine $177,846
Dr. Christine Smith, Md, MD
Family Medicine — Payments: $104,714
Family Medicine $104,714
Dr. Gerald Barber, M.d, M.D
Family Medicine — Payments: $18,510
Family Medicine $18,510
Dr. Stan Mays, M.d, M.D
Family Medicine — Payments: $17,123
Family Medicine $17,123
Dr. Yushen Lee, M.d, M.D
Family Medicine — Payments: $16,906
Family Medicine $16,906
Dr. Donald Carson, D.o, D.O
Family Medicine — Payments: $15,182
Family Medicine $15,182